Literature DB >> 12930368

Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.

G V Gregorio1, K Choudhuri, Y Ma, P Pensati, R Iorio, P Grant, J Garson, D P Bogdanos, A Vegnente, G Mieli-Vergani, D Vergani.   

Abstract

Autoantibodies to smooth muscle (SMA) and nuclear components (ANA) arise in the natural course of chronic infection with hepatitis C virus. In view of the growing evidence for 'molecular mimicry' as a mechanism of autoimmunity we investigated whether cross-reactive immune reactions between host smooth muscle/nuclear components and HCV antigens may contribute to the formation of SMA and ANA in chronic HCV infection. Computer-assisted protein database search methods were used to identify three smooth muscle (smoothelin698-717, myosin1035-1054, vimentin69-88) and three nuclear (matrin722-741, histone H2A11-30, replication protein A133-152) host antigens with the highest local sequence similarity to the HCV polyprotein and 20-mer peptides corresponding to these regions were constructed. Sera from 51 children with chronic HCV infection [median age: 8 (2-16); 27 boys], 26 SMA positive and five ANA positive, were tested for reactivity to the synthesized HCV peptides and their human homologues by enzyme linked immunosorbent assay (ELISA). Sera from patients with HBV infection and chronic liver disease of different aetiologies were used as controls. 'Double reactivity' to HCV peptides and smooth muscle/nuclear homologues was associated strongly with HCV infection (P < 0.001 for both). Humoral cross-reactivity was established as the basis for double recognition by competition ELISA. Double-reactivity to smooth muscle and HCV peptide antigens correlated with SMA positivity by indirect immunofluouresence (P = 0.05). Of 15 patients double-reactive to myosin1035-1054 and its HCV homologue, 13 recognized whole myosin by immunoblot. These results suggest that ANA and SMA in chronic HCV infection may arise, at least in part, as a consequence of cross-reactive immune responses to HCV and host smooth muscle/nuclear antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930368      PMCID: PMC1808793          DOI: 10.1046/j.1365-2249.2003.02229.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Prediction of sequential antigenic regions in proteins.

Authors:  G W Welling; W J Weijer; R van der Zee; S Welling-Wester
Journal:  FEBS Lett       Date:  1985-09-02       Impact factor: 4.124

2.  New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites.

Authors:  J M Parker; D Guo; R S Hodges
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

3.  The primary structure of the 32-kDa subunit of human replication protein A.

Authors:  L F Erdile; M S Wold; T J Kelly
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

4.  Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.

Authors:  G V Gregorio; B Portmann; J Karani; P Harrison; P T Donaldson; D Vergani; G Mieli-Vergani
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

5.  Coding sequence and growth regulation of the human vimentin gene.

Authors:  S Ferrari; R Battini; L Kaczmarek; S Rittling; B Calabretta; J K de Riel; V Philiponis; J F Wei; R Baserga
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

7.  A computer program for predicting protein antigenic determinants.

Authors:  T P Hopp; K R Woods
Journal:  Mol Immunol       Date:  1983-04       Impact factor: 4.407

8.  A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis.

Authors:  J C Homberg; N Stelly; I Andreis; N Abuaf; F Saadoun; J Andre
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

9.  The human histone H2A.Z gene. Sequence and regulation.

Authors:  C L Hatch; W M Bonner
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

10.  Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.

Authors:  S Wirth; L G Guidotti; K Ando; H J Schlicht; F V Chisari
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

View more
  34 in total

Review 1.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

2.  Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.

Authors:  Carlo Selmi; Angela Ceribelli; John M Vierling
Journal:  Semin Immunopathol       Date:  2012-12-19       Impact factor: 9.623

Review 3.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

4.  Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 5.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 6.  Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Yoh Zen; Robin Daniel Abeles; Charalambos Billinis; Albert Pares; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

7.  Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.

Authors:  Yuka Takahama; Hirofumi Uto; Shuji Kanmura; Makoto Oketani; Akio Ido; Kazunori Kusumoto; Satoru Hasuike; Kenji Nagata; Katsuhiro Hayashi; Sherri Stuver; Akihiko Okayama; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

Review 8.  Bacteria and primary biliary cirrhosis.

Authors:  Dimitrios P Bogdanos; Diego Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 9.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

10.  Virus-host coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hosts.

Authors:  Francisco P Lobo; Bruno E F Mota; Sérgio D J Pena; Vasco Azevedo; Andréa M Macedo; Andreas Tauch; Carlos R Machado; Glória R Franco
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.